| Anshul Mahendra Patel, MD | |
|
5671 Peachtree Dunwoody Rd, Suite 300 B, Atlanta, GA 30342-1786 | |
| (404) 778-6070 | |
| (678) 843-6350 |
| Full Name | Anshul Mahendra Patel |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 24 Years |
| Location | 5671 Peachtree Dunwoody Rd, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295725463 | NPI | - | NPPES |
| 366826914A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 60548 (Georgia) | Secondary |
| 207RC0001X | Internal Medicine - Clinical Cardiac Electrophysiology | 60548 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph's Hospital Of Atlanta, Inc | Atlanta, GA | Hospital |
| St Francis Hospital- Emory Healthcare | Columbus, GA | Hospital |
| Emory University Hospital | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Francis Physician Practices Llc | 8729381033 | 81 |
| The Emory Clinic, Inc | 8820901408 | 2687 |
News Archive
The Indiana Network for Patient Care (INPC) is expanding to serve patients in Terre Haute and Clinton, Indiana. Union Hospital joins 60 hospitals serving more than 6 million patients throughout the state in a network that allows physicians to securely access necessary information to make decisions critical to patient care.
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.
The connection between an influenza virus surface protein and a host cell lipid has been discovered by researchers at the University of Maine and the National Institutes of Health. Confirmation of direct interaction between the protein and lipid could lead to new antiviral therapies.
Women who have unprotected sexual intercourse or experience contraceptive failure can seek emergency contraception to reduce their chance of unintended pregnancy.
› Verified 1 days ago
| Entity Name | The Emory Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
The Indiana Network for Patient Care (INPC) is expanding to serve patients in Terre Haute and Clinton, Indiana. Union Hospital joins 60 hospitals serving more than 6 million patients throughout the state in a network that allows physicians to securely access necessary information to make decisions critical to patient care.
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.
The connection between an influenza virus surface protein and a host cell lipid has been discovered by researchers at the University of Maine and the National Institutes of Health. Confirmation of direct interaction between the protein and lipid could lead to new antiviral therapies.
Women who have unprotected sexual intercourse or experience contraceptive failure can seek emergency contraception to reduce their chance of unintended pregnancy.
› Verified 1 days ago
| Entity Name | North Atlanta Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316959869 PECOS PAC ID: 0840291944 Enrollment ID: O20070116000197 |
News Archive
The Indiana Network for Patient Care (INPC) is expanding to serve patients in Terre Haute and Clinton, Indiana. Union Hospital joins 60 hospitals serving more than 6 million patients throughout the state in a network that allows physicians to securely access necessary information to make decisions critical to patient care.
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.
The connection between an influenza virus surface protein and a host cell lipid has been discovered by researchers at the University of Maine and the National Institutes of Health. Confirmation of direct interaction between the protein and lipid could lead to new antiviral therapies.
Women who have unprotected sexual intercourse or experience contraceptive failure can seek emergency contraception to reduce their chance of unintended pregnancy.
› Verified 1 days ago
| Entity Name | St Francis Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326749417 PECOS PAC ID: 8729381033 Enrollment ID: O20160120002073 |
News Archive
The Indiana Network for Patient Care (INPC) is expanding to serve patients in Terre Haute and Clinton, Indiana. Union Hospital joins 60 hospitals serving more than 6 million patients throughout the state in a network that allows physicians to securely access necessary information to make decisions critical to patient care.
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.
The connection between an influenza virus surface protein and a host cell lipid has been discovered by researchers at the University of Maine and the National Institutes of Health. Confirmation of direct interaction between the protein and lipid could lead to new antiviral therapies.
Women who have unprotected sexual intercourse or experience contraceptive failure can seek emergency contraception to reduce their chance of unintended pregnancy.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anshul Mahendra Patel, MD 5671 Peachtree Dunwoody Rd, Suite 300 B, Atlanta, GA 30342-1786 Ph: (404) 778-6070 | Anshul Mahendra Patel, MD 5671 Peachtree Dunwoody Rd, Suite 300 B, Atlanta, GA 30342-1786 Ph: (404) 778-6070 |
News Archive
The Indiana Network for Patient Care (INPC) is expanding to serve patients in Terre Haute and Clinton, Indiana. Union Hospital joins 60 hospitals serving more than 6 million patients throughout the state in a network that allows physicians to securely access necessary information to make decisions critical to patient care.
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.
The connection between an influenza virus surface protein and a host cell lipid has been discovered by researchers at the University of Maine and the National Institutes of Health. Confirmation of direct interaction between the protein and lipid could lead to new antiviral therapies.
Women who have unprotected sexual intercourse or experience contraceptive failure can seek emergency contraception to reduce their chance of unintended pregnancy.
› Verified 1 days ago
Khadeja Jamilia Johnson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Howell Mill Rd Nw Ste 275, Atlanta, GA 30318 Phone: 404-756-1290 | |
Dr. Matthew J. Wilson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 755 Mt Vernon Hwy, Suite 530, Atlanta, GA 30328 Phone: 404-252-7970 Fax: 404-250-0553 | |
Kajal Patel, M.D, M.P.H Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1525 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-778-2700 | |
Dr. Earl Stewart Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2850 Paces Ferry Rd Se Ste 460, Atlanta, GA 30339 Phone: 678-556-4950 | |
Mary E. Bergh, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 980 Johnson Ferry Rd Ste 520, Atlanta, GA 30342 Phone: 404-303-3320 Fax: 404-303-3464 | |
John J Doran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1365 Clifton Rd Ne Bldg A, The Emory Clinic - Nephrology, Atlanta, GA 30322 Phone: 404-778-5380 | |
Frank A Anania, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1365 Clifton Rd Ne Ste B1266, The Emory Clinic - Gastroenterology, Atlanta, GA 30322 Phone: 404-778-3184 |